Results 101 to 110 of about 6,848 (153)

Data-driven hypothesis discovery from disease trajectories in multiple sclerosis. [PDF]

Front Immunol
Jodts N, Werthen-Brabants L, Aerts S, Peeters LM, Van Wijmeersch B, Herzeel C, Meertens C, Wuyts R, Dhaene T, Deschrijver D.   +9 more
europepmc   +1 more source

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy. [PDF]

Cancer
Marvin-Peek J, DiNardo CD, Loghavi S, Ravandi F, Borthakur G, Daver NG, Kadia TM, Jabbour E, Dunbar A, Tang G, Short NJ, Haddad FG, Abbas HA, Kugler E, Maiti A, Issa GC, Takahashi K, Bhalla K, Pemmaraju N, Alvarado Y, Shpall EJ, Popat U, Ramdial J, Champlin RE, Kantarjian HM, Garcia-Manero G, Senapati J.   +26 more
europepmc   +1 more source

A Rare Case of Erdheim-Chester Disease with Pseudoprogression in the CNS. [PDF]

J Blood Med
Moreno Vanegas Y, Kuhlman JJ, Jiang L, Agarwal A, Tun HW.   +4 more
europepmc   +1 more source

2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis. [PDF]

Ann Hematol
Liu N, Ma YR, Pang JN, Sun M-, Sun Y, Liu YJ, Hu JW, Li YH, Qiao ZQ, Duan MH, Gao SJ, Jiang Q, Hu LD.   +12 more
europepmc   +1 more source

DDX41-Mutated AML: A Case Report and Perspectives. [PDF]

JCO Precis Oncol
Yashar WM, Eide CA, Kurtz SE, Long N, Johnson KJ, Tognon CE, Druker BJ, Tyner JW, Swords R.   +8 more
europepmc   +1 more source

Incidence and Time to Diagnosis of Secondary Malignancies Among Patients With Hairy Cell Leukemia: A Systematic Review and Meta-analysis. [PDF]

Cureus
Miyashita A, Tanariyakul M, Wannaphut C, Saowapa S, Takaoka K.   +4 more
europepmc   +1 more source

Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia. [PDF]

Front Public Health
Al-Jedai A, Almudaiheem H, Al-Suweidan F, Jumah MA, Al-Thobaiti A, Alzureiqan F, Abu Ras W, Al-Dosari FM, Malik YA, Dhopte P, Ojeil R.   +10 more
europepmc   +1 more source

Comparative preclinical drug response analyses of T-prolymphocytic leukemia reveal no differences between known gene expression subgroups. [PDF]

Biol Direct
Mikhaylenko N, Braun T, Timonen S, Mustjoki S, Herling M, Seifert M.   +5 more
europepmc   +1 more source

Extensive peripheral immunoglobulin repertoire analyses in people with multiple sclerosis reveal disease-specific signatures and distinct treatment effects of disease modifying drugs. [PDF]

J Neuroinflammation
Vasilenko N, Ruschil C, Stadelmaier J, Tieck MP, Schembecker S, Owens GP, Bennett JL, Berthele A, Ziemann U, Poli S, Snaidero N, Nahnsen S, Jarboui MA, Bichmann L, Gabernet G, Kowarik MC.   +15 more
europepmc   +1 more source

Special Issue "Neurodegenerative Diseases: Molecular Mechanisms and Therapies, 3rd Edition". [PDF]

Int J Mol Sci
Zhou Z, Kihara AH.
europepmc   +1 more source